BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 12375039)

  • 1. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
    Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
    Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].
    Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K; Matsushita Y; Yonezawa S; Nakano S; Shirao K; Natsugoe S; Sueyoshi K; Aikou T; Sato E
    Hum Pathol; 2000 Apr; 31(4):428-33. PubMed ID: 10821488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
    Ajisaka H; Fushida S; Yonemura Y; Miwa K
    Hepatogastroenterology; 2001; 48(42):1788-92. PubMed ID: 11813625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
    Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
    J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
    Wei B; Chen L; Li J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of peroxisome proliferator-activated receptor in histologically different human gastric cancer tissues.
    Nomura S; Nakajima A; Ishimine S; Matsuhashi N; Kadowaki T; Kaminishi M
    J Exp Clin Cancer Res; 2006 Sep; 25(3):443-8. PubMed ID: 17167986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer.
    Dong WG; Yu QF; Xu Y; Fan LF
    Dig Dis Sci; 2008 Jul; 53(7):1811-7. PubMed ID: 17999183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of galectin 3 and Sambucus nigra agglutinin and their clinicopathological significance in benign and malignant lesions of stomach].
    Zhou JP; Yang ZL; Liu DC; Zhou JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):297-300. PubMed ID: 19434543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype.
    Yamashita H; Kitayama J; Ishikawa M; Nagawa H
    J Surg Oncol; 2007 Mar; 95(4):324-31. PubMed ID: 17066404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
    Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
    Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
    Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
    Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of E-cadherin mRNA expression in primary tumors and metastatic foci of gastric cancer].
    Yang J; Dai DQ
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):25-8. PubMed ID: 15771793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast.
    Fernandez-Aguilar S; Noël JC
    APMIS; 2008 Jan; 116(1):33-40. PubMed ID: 18254778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
    Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
    Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
    Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
    Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
    Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.